Follow my journey to achieve Financial FREEDOM with Stocks, Dividend Growth, Affiliate Marketing, and Real Estate! Help this channel grow by: Like my video, Drop A Comment, Subscribe Today Why? To see

Summary It’s true that higher yields are usually a sign that something’s not right. It tends to mean the dividend’s in line for a cut, followed by the stock price. As with all the portfolios I’m a part

Summary Hot water heater maker A. O. Smith has underperformed the S&P 500 dramatically in recent years. Despite that, it has delivered reasonably strong business results and has continued to increase

Summary A great diversification allowed me to not suffer from bad news coming from a few companies. Texas Instruments is facing many headwinds at the same time. Hasbro has created more noise than most

Summary Flowers Foods has a solid track record of performance and dividend growth. The company's dividend has grown each of the past 18 years. However, the company suffers from dealing in an industry that

Summary In an article in the Globe & Mail, Benjamin Felix claimed focusing on dividend stocks would prevent from getting an optimal return and that index ETF investing is a lot better. Ben's says focusing

Summary While I prefer to invest a good part of my money in the U.S. market (for diversification and potential), I am now able to find some hidden gems in the Canadian market. Evolving in an oligopoly

Summary The premise of many "anti-dividend" theses is based on the Modigliani-Miller theorem. Most dividend growers will show a strong dividend triangle: revenue growth, earnings growth and dividend

The long-term, cash squeeze, high dividend growth strategy is commonly used by companies all over the world. Many investors are misled by the offset that occurs in company data when this strategy is deployed.

Yesterday we presented part 1 of our analysis on the biosimilar pharmaceuticals market. Today we'll be presenting part 2 and picking up where we left off with a Brief History of Biosimilars. Brief History

Introduction The type of pharmaceutical drug being referenced throughout this discussion goes by many different names. These terms include “biopharmaceuticals”, “biological medical products”, or simply

Our Model Portfolio contains companies that have attained a status referred to as an SDG. But what is that? How does a company attain such a status? An SDG is a company that pays a dividend which increases,

In Part 1 we looked at some of the history of the recent elevated interest in dividend growth investing and dividend stocks in general. In this article, the discussion continues with other parameters that

The meaning of the term “dividend growth investing” (DGI) has become extremely varied. Given its wide usage, one can’t assume any particular strategy is referenced whenever the term is used. Most practitioners

The term “dividend growth investing” (DGI) has taken on many different meanings. This term is used by several hundred funds and ETFs, all of which vary in their approach. Among the practitioners of this